Skip to main content

Cefamandole Pregnancy and Breastfeeding Warnings

Brand names: Mandol

Cefamandole Pregnancy Warnings

Cefamandole has been assigned to pregnancy category B by the FDA. Animal studies failed to reveal evidence of fetal harm. There are no controlled data in human pregnancies. Cefamandole should only be given during pregnancy when need has been clearly established.

See references

Cefamandole Breastfeeding Warnings

Cefamandole is excreted into human milk in small amounts. Adverse effects in the nursing infant are unlikely. The American Academy of Pediatrics classifies other cephalosporins as compatible with breast-feeding.

See references

References for pregnancy information

  1. (2001) "Product Information. Mandol (cefamandole)." Lilly, Eli and Company
  2. Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J (2001) "Use of cephalosporins during pregnancy and in the presence of congenital abnormalities: A population-based, case-control study." Am J Obstet Gynecol, 184, p. 1289-96

References for breastfeeding information

  1. (2001) "Product Information. Mandol (cefamandole)." Lilly, Eli and Company
  2. Briggs GG, Freeman RK, Yaffe SJ.. (1998) "Drugs in Pregnancy and Lactation." Baltimore, MD: Williams & Wilkins

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.